Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Sanofi
02 5Dr. Reddy's Laboratories
03 4Alfred E Tiefenbacher GmbH
04 2NanoAlvand
05 1Naprod Life Sciences
06 1Accord healthcare
07 1Adamed Pharma
08 2Amneal Pharmaceuticals
09 3Apotex Inc
10 2Bluepharma
11 1CHEMO
12 6Centocor
13 1Cipla Medpro South Africa
14 2DR REDDY'S LABORATORIES LTD
15 2DelNova Healthcare
16 1Devatis AG
17 1Dr Reddy's Laboratories (Pty) Ltd
18 1Eurofarma Laboratorios S.A
19 1Florida Pharmaceutical Products
20 1Forrester Pharma
21 2GLENMARK SPECLT
22 1Hetero Drugs
23 1Hikma Pharmaceuticals
24 3JAMP PHARMA
25 4Janssen-Cilag
26 1Jiangsu Hengrui Medicine
27 1Jodas Expoim Pvt. Ltd
28 4Johnson & Johnson Innovative Medicine
29 1Kwality Pharmaceuticals
30 1Laboratorio Eczane Pharma
31 2MARCAN PHARMACEUTICALS INC
32 2MSN Laboratories
33 1Natco Pharma (Canada) Inc
34 2Novugen
35 2Olon S.p.A
36 2Pharmascience Inc.
37 2Qilu Pharmaceutical
38 1RANBAXY LABORATORIES LIMITED
39 1Rising Pharmaceuticals Inc
40 2Sakar Healthcare
41 4Sandoz B2B
42 1Spirig Healthcare
43 1Sun Pharmaceutical Industries Limited
44 3Tecnimede
45 2Teva Pharma Australia
46 4Teva Pharmaceutical Industries
47 1TherDose Pharma
48 4Viatris
49 1Wockhardt
50 1World Medicine
51 1Zentiva
52 1Éticos
53 1Blank
01 1Abiraterone 250Mg 120 Unita' Oral Use
02 1Antic-calc Tablet
03 2Coated Tablet
04 1FCT
05 7Film Coated Tablet
06 10Filmtabl
07 2Oral Solid Dosage Form
08 1Oral Tablet
09 6TAB
10 20TABLET
11 25TABLET;ORAL
12 15Tablet
13 4Tablets
14 2tablet
15 3Blank
01 1Available Dossier- US-EU-RoW
02 1DISCN
03 4EU Dossier Readiness-Q1 2019
04 7Generic
05 1Lead Market Dossiers- Approved in US
06 2Lead Market Dossiers- Filed
07 2Originator
08 24RX
09 58Blank
01 1ABIRATERONE
02 22ABIRATERONE ACETATE
03 1ABITIG
04 2AKEEGA
05 2APO-ABIRATERONE FILM COATED TABLETS
06 1Abirateron Accord
07 1Abirateron Devatis
08 2Abirateron Sandoz
09 1Abirateron Spirig HC
10 2Abirateron Viatris
11 1Abirateron Zentiva
12 1Abirateron-Teva
13 1Abiraterone Cipla
14 2Abiraterone-Teva
15 1BIRATER
16 1Heteran 250
17 2JAMP ABIRATERONE
18 2MAR-ABIRATERONE
19 1NAT-ABIRATERONE
20 2PMS-ABIRATERONE
21 1Protyga
22 2REDDY-ABIRATERONE
23 2SANDOZ ABIRATERONE
24 1Teronred 250
25 1Xateron
26 2Xybrone
27 1YONSA
28 5ZYTIGA
29 1ZYTIGA 250 MG
30 1ZYTIGA 500 MG
31 7Zytiga
32 27Blank
01 1Argentina
02 4Australia
03 2Brazil
04 18Canada
05 1China
06 1Czech Republic
07 4Germany
08 11India
09 2Iran
10 3Italy
11 1Norway
12 1Paraguay
13 1Poland
14 5Portugal
15 7South Africa
16 1Spain
17 1Sweden
18 10Switzerland
19 1Turkey
20 25USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Abirateron Zentiva
Dosage Form : Filmtabl
Dosage Strength : 500mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2020-05-18
Application Number : 208416
Regulatory Info : RX
Registration Country : USA
Regulatory Info : EU Dossier Readiness-Q1 2019
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2019
Registration Country : Germany
Regulatory Info :
Registration Country : Iran
Brand Name : Xybrone
Dosage Form : Film Coated Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablets
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2023-09-01
Application Number : 208416
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
Regulatory Info : EU Dossier Readiness-Q1 2019
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2019
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q1 2019
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2019
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q1 2019
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2019
Registration Country : Germany
Regulatory Info :
Registration Country : Iran
Brand Name : Xybrone
Dosage Form : Film Coated Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-01-07
Application Number : 208327
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2020-12-23
Application Number : 208327
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2018-10-31
Application Number : 208453
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ZYTIGA
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2011-04-28
Application Number : 202379
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ZYTIGA
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2017-04-14
Application Number : 202379
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2018-10-31
Application Number : 208339
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-07-10
Application Number : 210686
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2024-04-24
Application Number : 210686
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-02-25
Application Number : 208371
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : YONSA
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2018-05-22
Application Number : 210308
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2018-10-31
Application Number : 208432
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2023-01-26
Application Number : 210726
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2018-10-31
Application Number : 208446
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2020-12-14
Application Number : 208446
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-02-27
Application Number : 208380
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-10-16
Application Number : 209227
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : RX
Registration Country : USA
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2022-05-19
Application Number : 209227
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?